Discover Cochlear Limited's Q2 2025 earnings insights: strong implant growth, upcoming product launches, and strategic investments amid Services ...

The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ ...

Tax reform needs to be firmly on the agenda ahead of the looming federal election, Cochlear chief executive Dig Howitt says, ...

Cochlear expects full-year earnings to come in at the lower end of guidance, despite rising sales of its implants.

A cochlear implant may benefit those with severe hearing loss. Implanted in the cochlea, it has many advantages, but there are also drawbacks. The cochlea is the spiral-shaped organ in your inner ear.

Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at ...

The Cochlear Ltd (ASX: COH) share price is sinking on Friday after the hearing solutions company's half year result ...

Cochlear (ASX: COH) shares are trading at the lowest level since December 2023 after the company reported a ...

ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare.

Cochlear Limited (ASX: COH) has reported a 5 percent increase in revenue to $1,170 million for the first half of the 2025 ...

Cochlear (ASX:COH) will pay an 8% higher dividend, with profits up 7% for the half year to the end of 2024 despite falling ...

The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 2.80 Billion in ...